KIF1A-mediated trafficking is required for neuronal autophagy in human neurons

Technical Summary: KIF1A-Mediated Trafficking is Required for Neuronal Autophagy in Human Neurons

Problem Statement
Mutations in the molecular motor protein KIF1A cause KIF1A-Associated Neurological Disorder (KAND), a spectrum of neurodevelopmental and neurodegenerative conditions. While KIF1A is well-established as a driver of synaptic vesicle precursor (SVP) and dense core vesicle (DCV) trafficking, the impact of KIF1A loss on other critical neuronal transport pathways, specifically autophagy, remains unexplored in human neurons. Autophagy is essential for neuronal homeostasis, involving the sequestration of cargo into autophagosomes in the distal axon, their retrograde transport to the soma, and subsequent fusion with lysosomes for degradation. Given that KIF1A transports lysosomes and that C. elegans studies suggest a role in ATG9 trafficking, the authors investigated whether KIF1A dysfunction contributes to KAND pathology via deficits in the autophagy-lysosomal pathway.

Methodology
The study utilized human induced pluripotent stem cell (iPSC)-derived cortical-like glutamatergic neurons. The authors employed CRISPR/Cas9 gene editing to generate three specific lines:

1. Wild Type (WT): Control neurons.
2. C92 Null:* Homozygous neurons expressing an early stop codon (C92*), resulting in a complete loss of KIF1A protein (verified as a null mutation).
3. C92*Het: Heterozygous neurons expressing the same truncating mutation, modeling the clinical presentation of KAND patients.

Key experimental approaches included:

• Immunocytochemistry and Microfluidics: Neurons were cultured in microfluidic chambers to physically separate somas from axons, allowing for the specific analysis of distal axonal trafficking.
• Live-Cell Imaging: Time-lapse microscopy was used to track the dynamics of various organelles using fluorescent probes and tagged proteins (e.g., DAPRED for autophagosomes, mScarlet-LC3, Halo-DFCP1 for biogenesis, mNeon-LAMP1 for lysosomes, SYTO RNASelect for RNA, and TMRE for mitochondrial potential).
• Western Blotting: Used to assess protein levels (KIF1A, LAMP1, LC3, Cathepsin D, p-TFEB) and autophagic flux (LC3-II/LC3-I ratios) in the presence or absence of Bafilomycin A1 (BafA1).
• Quantitative Analysis: Kymographs were generated to measure vesicle flux, density, and colocalization events. Statistical analyses included unpaired t-tests, ANOVA, and linear mixed-effects models.

Key Results

1. Disruption of ATG9 Trafficking: In KIF1A-null neurons, the transmembrane lipid scramblase ATG9, essential for autophagosome biogenesis, was significantly retained in the somatic trans-Golgi network (TGN). Consequently, ATG9 levels were depleted in the distal axon, indicating KIF1A is required for anterograde transport of ATG9 vesicles to autophagy initiation sites.
2. Impaired Autophagosome Biogenesis and Density: The loss of distal ATG9 led to a significant reduction in the density of autophagosomes in the distal axon. Live imaging of DFCP1 (a marker for omegosomes) and LC3 revealed a slower rate of autophagosome biogenesis in KIF1A-null neurons compared to WT.
3. Lysosomal Depletion and Maturation Defects: KIF1A-null axons exhibited a marked depletion of lysosomes (LAMP1-positive), which accumulated in the soma. This depletion correlated with a failure in autophagosome maturation; while the ratio of acidified (mCherry-only) to non-acidified (GFP-mCherry) LC3 vesicles was similar between genotypes, the absolute number of acidified vesicles was drastically reduced due to the overall lower density of both organelles.
4. RNA Granule Depletion: Consistent with the known link between lysosomes and RNA transport, KIF1A-null axons showed reduced levels of total RNA and FMRP-positive RNA granules.
5. Mitochondrial Morphology vs. Function: While mitochondrial density and flux were unchanged, mitochondria in KIF1A-null neurons appeared smaller and more punctate. However, mitochondrial membrane potential (TMRE intensity) and ATP levels remained comparable to WT, suggesting functional integrity despite morphological changes.
6. Haploinsufficiency in Heterozygous Neurons: Crucially, neurons heterozygous for the C92* mutation (C92*Het) displayed significant, though less severe, deficits compared to the null. They showed reduced KIF1A expression, decreased autophagosome density, smaller autophagosome sizes, reduced lysosomal density and flux, and a lower fraction of acidified autophagosomes. This indicates that KIF1A is not haplo-sufficient for maintaining normal autophagy and lysosomal trafficking in human neurons.

Significance and Claims
The authors conclude that KIF1A-mediated transport is critical for neuronal autophagy, extending the known pathophysiology of KAND beyond synaptic dysfunction. The study demonstrates that KIF1A loss leads to a cascade of defects: mislocalization of ATG9, reduced autophagosome biogenesis, depletion of axonal lysosomes, and impaired autophagosome maturation.

A primary claim of the paper is that KIF1A is not haplo-sufficient in human neurons. The observation that heterozygous C92* neurons exhibit significant autophagic deficits suggests that therapeutic strategies for KAND targeting the reduction of mutant alleles (e.g., antisense oligonucleotides) must carefully consider the risk of further lowering KIF1A levels below a critical threshold required for autophagy. The authors propose that autophagic deficits contribute to the progressive neurodegeneration and diverse clinical spectrum seen in KAND patients, highlighting the autophagy-lysosomal pathway as a potential target for therapeutic intervention to alleviate toxic buildup and slow disease progression.